课题基金 / 基金详情

CCDC3 is specifically upregulated in omental adipose tissue in subjects with abdominal obesity

CCDC3 is specifically upregulated in omental adipose tissue in subjects with abdominal obesity
CCDC3 在腹部肥胖受试者的网膜脂肪组织中特异性上调
批准号:
23591304
负责人:
UGI Satoshi
金额:
$3.41万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013

项目摘要

项目成果

UGI Satoshi的其他基金

相关文献

中文摘要
翻译
为了寻找内脏肥胖的新标记物,我们采集了43名日本男性的内脏和皮下脂肪组织。我们使用从五名腹型肥胖男性和五名非肥胖男性的内脏和皮下脂肪组织中获得的RNA进行了微阵列分析。CCDC3(编码卷曲结构域蛋白3)在腹型肥胖者的大网膜脂肪组织中表达上调(3.07倍),而在皮下脂肪组织中的表达上调(0.89倍)。在两种不同的肥胖小鼠模型中也发现了相似的表达模式。在对所有43名男性的分析中,大网膜中的CCDC3mRNA水平与腰围和BMI呈正相关,而皮下脂肪组织中的CCDC3mRNA水平与腰围和BMI呈正相关。Western blotting证实CCDC3是一种分泌型蛋白,提示CCDC3是一种潜在的内脏肥胖症的生物标志物。
英文摘要
To search for novel markers of visceral adiposity, visceral and subcutaneous adipose tissues were obtained from 43 Japanese men. We conducted microarray analysis using RNA from visceral and subcutaneous adipose tissues obtained from five men with abdominal obesity and five non-obese men. The mRNA expression of CCDC3 (encoding coiled-coil domain-containing protein 3) was upregulated in omental adipose tissues from abdominally obese subjects (3.07-fold) but not in subcutaneous adipose tissues (0.89-fold). Similar expression patterns were found in two distinct mouse models of obesity. In the analysis of all 43 men, CCDC3 mRNA levels in omental, but not in subcutaneous adipose tissue, were positively correlated with waist circumference and BMI. CCDC3 was predicted to be a secretory protein, which was confirmed by western blotting.These results suggest that CCDC3 is a potential biomarker for estimating visceral adiposity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CCDC3 is specifically upregulated in omental adipose tissue in subjects with abdominal obesity.
在腹部肥胖受试者的网膜脂肪组织中,CCDC3 特别上调。
DOI: 10.1002/oby.20645
发表时间: 2014
期刊: Obesity
影响因子: 6.9
作者: [Satoshi Ugi, Shiro Maeda, Yoshihiro Kawamura, Masa-aki Kobayashi, Minako Imamura, Takeshi Yoshizaki, Katsutaro Morino, Osamu Sekine, Hiroshi Yamamoto, Toru Tani, Masatomo Rokushima, Atsunori Kashiwagi, Hiroshi Maegawa]
通讯作者: Hiroshi Maegawa
新たなメタボリックシンドローム発症遺伝子同定のための網羅的研究ヒト生検脂肪組織マイクロアレイ解析と全ゲノムSNP解析を用いて, Therapeutic Research
使用人体活检脂肪组织微阵列分析和全基因组 SNP 分析识别新的代谢综合征发病基因的综合研究,治疗研究
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [Satoshi Ugi, Shiro Maeda, Yoshihiro Kawamura, Masa-aki Kobayashi, Minako Imamura, Takeshi Yoshizaki, Katsutaro Morino, Osamu Sekine, Hiroshi Yamamoto, Toru Tani, Masatomo Rokushima, Atsunori Kashiwagi, Hiroshi Maegawa, 卯木智,西尾善彦,他7名]
通讯作者: 卯木智,西尾善彦,他7名
The role of AP2β, the molecule which leads to adipocyte hypertrophy, in the metabolic syndrome
  • 批准号:
    19591045
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2007
  • 负责人:
    UGI Satoshi
  • 依托单位:
The Pathophysiological Role of Protein Phosphatase 2A (PP2A) in metabolic Syndrome
  • 批准号:
    17590927
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.24万
  • 财政年份:
    2005
  • 负责人:
    UGI Satoshi
  • 依托单位: